# Documentation review

Date: October 7, 2026. Scope: PRD, plan, and policy documents only.

## Acceptance review

- MET: All named uploaded-template sections appear in original order; empty headings and instruction material were removed.
- MET: Original template was copied before drafting and remains unchanged; SHA-256 remained FEB08AA6FE09C5A162F86F2057271E7817892C04866F3A46AC1F30C4D7A68BBF.
- MET: CVS store is location context only; synthetic stock, evaluation responses, metric targets, and policy assumptions are explicit.
- MET: Two read-only proposed tool contracts; no CVS endpoint, credentials, live integration, or API success is invented.
- MET: Local required-data failures block affected recommendations; FDA failure does not produce false reassurance.
- MET: Calculation, units, threshold boundaries, zero-use behavior, and zero-stock behavior agree across PRD and policy.
- MET: Three cases have specific prewritten expected outputs, including contradictory local/external signals and an adversarial failure.
- MET: No operational write or clinical authority is included; live-use dependencies and future exclusions remain visible.

## Arithmetic and boundary review

Case 1 total usage = 4*20 + 10*10 = 180 units; average = 180/14; supply = 80/(180/14) = 6.222222222 days, displayed 6.22. The local result is above 5 days while external risk independently prompts human review. At 2 days classify CRITICAL; at 5 classify LOW. Zero usage cannot produce an infinite duration. These are specification checks, not executed agent evaluations.

## Safety review and limits

Two document inspection passes checked tool scope and the system prompt against authority, data, matching, and failure boundaries. No executable API, authentication, database, deployment, or operational security surface exists in this deliverable; security enforcement and API runtime tests are NOT TESTABLE until implementation. No claim of security clearance, live inventory accuracy, or clinical compliance is made. Prototype metrics have not been measured.

## Preservation and recovery

The original uploaded template is intact and no existing project file was overwritten. Drafts can be regenerated from that source and PLAN.md. No separate backup service or retention policy was configured; disaster recovery is not verified. The requested destination copy is a delivery copy, not a verified OneDrive cloud restore or offsite backup.

## Line Return Reference

- Pharmacy Inventory Logistics[PRD]-draft.md: lines 1-197 — completed template copy; all deliverable lines are new.
- PLAN.md: lines 1-47 — approved setup, scope, and unknowns.
- POLICY.md: lines 1-53 — synthetic prototype policy.
- REVIEW.md: lines 1-43 — review evidence and limitations.

## Secondary Checks

- Trailing whitespace: PASS.
- Markdown fences: PASS; the PRD has one balanced system-prompt block.
- Direction/placeholder scan: PASS; no template directions or unfilled template markers remain.

## Verdict

Documentation acceptance criteria met. Application implementation and live-use validation remain separate work.
